Self-reported antihypertensive medication use demonstrated near-perfect agreement with objective measures (Kappa 0.867, sensitivity 98.4%) among individuals living with HIV and hypertension in Malawi.
Cross-Sectional (n=233)
Yes
Does self-reported antihypertensive use accurately reflect objective measures of use in individuals living with HIV and hypertension in a resource-limited setting?
Self-reported antihypertensive medication use shows near-perfect agreement with objective measures among individuals living with HIV in Malawi, suggesting it is a reliable tool for clinical assessment in resource-limited settings.
Effect estimate: Kappa 0.867
In sub-Saharan Africa, people living with HIV are at increased risk for hypertension, and rates of controlled hypertension are extremely low (1).In resource-poor settings in sub-Saharan Africa, such as Malawi, medication availability is limited by supply and cost constraints (2, 3), and patients often struggle to fill prescriptions (2).The absence of electronic health records in many health facilities further complicates the verification and tracking of patients' use of antihypertensives.Self-reports of antihypertensive medication use can be susceptible to biases and inaccuracies, particularly in settings with low health literacy, and inaccurate self-reports could lead to suboptimal medical management.Objective data from medical records are typically considered more reliable, but in low-resource settings, medical records are not always available, necessitating alternative measures.In this study, we examined the reliability of selfreported antihypertensive medication use among individuals living with HIV and hypertension in Malawi.
Jere et al. (Thu,) conducted a cross-sectional in HIV and hypertension (n=233). Self-reported antihypertensive use vs. Objective measure of antihypertensive use was evaluated on Concordance between self-reported and objective measures of antihypertensive use (Kappa 0.867). Self-reported antihypertensive medication use demonstrated near-perfect agreement with objective measures (Kappa 0.867, sensitivity 98.4%) among individuals living with HIV and hypertension in Malawi.